42. Misbranding of Tablets Arbolone.    U. S. v. 188 Packages of Tablets Arbolone.
Default decree of condemnation and destruction.    (F. D. C. No. 216.    Sample
-     No. 55108-D.)
This drug consisted of tablets containing desiccated thyroid and extracts of
plant drugs including an iodine-containing drug such as bladder wrack and a
laxative drug such as cascara sagrada. It was recommended in its labeling
as a treatment for obesity with dosage of one to two tablets, beginning with
one after each meal and increasing the dose to Two tablets after the third day,
and continuing until the desired reduction resulted, after which the tablets
might be taken occasionally as a preventive. It was recommended further that
the dose be reduced if headache, vertigo, or heart palpitation ensued, and that
the treatment be continued several weeks or months as the case might require.
It would be dangerous to health when used in the dosage or with the fre-
quency or duration so prescribed, recommended, or suggested. Its labeling
failed to reveal facts material in the light of the representations set forth
in the labeling, or material with respect to consequences which might result
from the use of the article under the conditions of use prescribed in the label-
ing, and failed to bear warnings against its use in those pathological condi-
tions or by children where its use might be dangerous to health, or against
unsafe dosage or methods or duration of administration or application.
On April 11, 1939, the United States attorney for the Northern District of
Illinois filed a libel against 188 packages of Tablets Arbolone at Chicago, 111.;
alleging that the article had been shipped in interstate commerce on or about
February 15, 1939, by the Arbolone Co. from Dayton, Ohio; and charging
that it was misbranded for the reasons appearing above.
On June 20, 1939, no claimant having appeared, judgment of condemnation
was entered and the product was ordered destroyed.
MISCELLANEOUS